These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
682 related items for PubMed ID: 31537705
21. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome. Valassina N, Brusco S, Salamone A, Serra L, Luoni M, Giannelli S, Bido S, Massimino L, Ungaro F, Mazzara PG, D'Adamo P, Lignani G, Broccoli V, Colasante G. Nat Commun; 2022 Jan 10; 13(1):161. PubMed ID: 35013317 [Abstract] [Full Text] [Related]
27. Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility. Dutton SB, Makinson CD, Papale LA, Shankar A, Balakrishnan B, Nakazawa K, Escayg A. Neurobiol Dis; 2013 Jan 10; 49():211-20. PubMed ID: 22926190 [Abstract] [Full Text] [Related]
28. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome. Tai C, Abe Y, Westenbroek RE, Scheuer T, Catterall WA. Proc Natl Acad Sci U S A; 2014 Jul 29; 111(30):E3139-48. PubMed ID: 25024183 [Abstract] [Full Text] [Related]
33. Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome. Almog Y, Fadila S, Brusel M, Mavashov A, Anderson K, Rubinstein M. Neurobiol Dis; 2021 Jan 29; 148():105209. PubMed ID: 33271326 [Abstract] [Full Text] [Related]
34. Propagation of sharp wave-ripple activity in the mouse hippocampal CA3 subfield in vitro. Schieferstein N, Del Toro A, Evangelista R, Imbrosci B, Swaminathan A, Schmitz D, Maier N, Kempter R. J Physiol; 2024 Oct 29; 602(19):5039-5059. PubMed ID: 39216085 [Abstract] [Full Text] [Related]
35. Hippocampal deletion of NaV1.1 channels in mice causes thermal seizures and cognitive deficit characteristic of Dravet Syndrome. Stein RE, Kaplan JS, Li J, Catterall WA. Proc Natl Acad Sci U S A; 2019 Aug 13; 116(33):16571-16576. PubMed ID: 31346088 [Abstract] [Full Text] [Related]
36. Exploring Ripple Waves in the Human Brain. Takagi S. Clin EEG Neurosci; 2023 Nov 13; 54(6):594-600. PubMed ID: 34287087 [Abstract] [Full Text] [Related]
37. Cell-Selective Adeno-Associated Virus-Mediated SCN1A Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and Is Well Tolerated in Nonhuman Primates. Tanenhaus A, Stowe T, Young A, McLaughlin J, Aeran R, Lin IW, Li J, Hosur R, Chen M, Leedy J, Chou T, Pillay S, Vila MC, Kearney JA, Moorhead M, Belle A, Tagliatela S. Hum Gene Ther; 2022 Jun 13; 33(11-12):579-597. PubMed ID: 35435735 [Abstract] [Full Text] [Related]
39. Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation. Hedrich UB, Liautard C, Kirschenbaum D, Pofahl M, Lavigne J, Liu Y, Theiss S, Slotta J, Escayg A, Dihné M, Beck H, Mantegazza M, Lerche H. J Neurosci; 2014 Nov 05; 34(45):14874-89. PubMed ID: 25378155 [Abstract] [Full Text] [Related]
40. Inhibitory Parvalbumin Basket Cell Activity is Selectively Reduced during Hippocampal Sharp Wave Ripples in a Mouse Model of Familial Alzheimer's Disease. Caccavano A, Bozzelli PL, Forcelli PA, Pak DTS, Wu JY, Conant K, Vicini S. J Neurosci; 2020 Jun 24; 40(26):5116-5136. PubMed ID: 32439703 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]